Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Adial Pharmaceuticals
(NASDAQ:ADIL)
Intraday
$1.74
0.03
[1.75%]
After-Hours
$1.74
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.74
0.03
[1.75%]
At close: Apr 25
$1.74
0
[0.00%]
After Hours: 5:54PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Adial Pharmaceuticals Stock (NASDAQ:ADIL)
Adial Pharmaceuticals Stock (NASDAQ: ADIL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
11 hours ago
Monday, April 22, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
3 days ago
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
Vandana Singh
-
3 days ago
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'This patent expands Adial's intellectual property protection and covers the combination of the Company's proprietary genetic diagnostic to identify patients with specific genotypes
Benzinga Newsdesk
-
3 days ago
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Granted Key Patent From The United States Patent And Trademark Office
Benzinga Newsdesk
-
3 days ago
Wednesday, April 17, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Apr 17, 2024, 12:31PM
Monday, April 15, 2024
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Apr 15, 2024, 2:11PM
Friday, April 12, 2024
Adial Pharmaceuticals Files Prospectus Relates To Resale From Time To Time Of Up To 2.36M Shares Of Common Stock By Selling Stockholders
Benzinga Newsdesk
-
Apr 12, 2024, 4:27PM
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Apr 12, 2024, 2:47PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Apr 12, 2024, 12:31PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 12, 2024, 8:09AM
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 12, 2024, 5:32AM
Thursday, April 11, 2024
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 11, 2024, 6:14AM
Wednesday, April 10, 2024
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
Benzinga Neuro
-
Apr 10, 2024, 10:19PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Apr 10, 2024, 4:31PM
S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings
Avi Kapoor
-
Apr 10, 2024, 2:34PM
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 10, 2024, 2:07PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Apr 10, 2024, 12:31PM
Crude Oil Edges Higher; Marin Software Shares Jump
Avi Kapoor
-
Apr 10, 2024, 12:15PM
Dow Falls Over 1%; US Inflation Rate Accelerates In March
Avi Kapoor
-
Apr 10, 2024, 10:20AM
Market-Moving News for April 10th
Benzinga Newsdesk
-
Apr 10, 2024, 8:39AM
Adial Pharmaceuticals shares are trading higher after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.
Benzinga Newsdesk
-
Apr 10, 2024, 8:30AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Apr 10, 2024, 8:09AM
EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance
Vandana Singh
-
Apr 10, 2024, 8:00AM
EXCLSUIVE: Adial Pharmaceuticals Tells Benzinga Co Announces Peer-Reviewed Publication Highlighting Safety Data And High Patient Compliance In A Clinical Trial Of AD04 As A Potential Treatment For Alcohol Disorder
Benzinga Newsdesk
-
Apr 10, 2024, 8:00AM
Monday, April 08, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 8, 2024, 8:09AM
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Apr 5, 2024, 4:31PM
Tuesday, April 02, 2024
Adial Pharmaceuticals FY23 Cash And Cash Equivalents Were $2.8M As Of Dec. 31, 2023
Benzinga Newsdesk
-
Apr 2, 2024, 8:37AM
Friday, March 15, 2024
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 15, 2024, 8:13AM
Monday, March 11, 2024
Peering Into Adial Pharmaceuticals's Recent Short Interest
Benzinga Insights
-
Mar 11, 2024, 4:15PM
Thursday, March 07, 2024
Watching Adial Pharmaceuticals; Traders Circulate Unconfirmed Analyst Comments Suggesting "Management Is In Advanced Discussions With A Large Pharma Partner In The Addiction Marketplace In The U.S., EU, Or Both; Buy Rating With $21 PT"
Benzinga Newsdesk
-
Mar 7, 2024, 10:13AM
Monday, March 04, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 4, 2024, 8:09AM
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 4, 2024, 8:04AM
Friday, March 01, 2024
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 1, 2024, 1:19PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 1, 2024, 12:34PM
US Stocks Mixed; Dell Posts Upbeat Results
Avi Kapoor
-
Mar 1, 2024, 9:47AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 1, 2024, 8:09AM
Thursday, February 29, 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 29, 2024, 2:00PM
Wednesday, February 28, 2024
Why Adial Pharmaceuticals Stock Is Blasting Off
Erica Kollmann
-
Feb 28, 2024, 2:43PM
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Avi Kapoor
-
Feb 28, 2024, 2:30PM
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 28, 2024, 2:02PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 28, 2024, 12:31PM
Adial Pharmaceuticals shares are trading higher after the company announced that it was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.
Benzinga Newsdesk
-
Feb 28, 2024, 12:29PM
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
Avi Kapoor
-
Feb 28, 2024, 12:25PM
Dow Dips 200 Points; TJX Posts Upbeat Sales
Avi Kapoor
-
Feb 28, 2024, 10:12AM
EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Lead Product For Alcohol Use Disorder
Vandana Singh
-
Feb 28, 2024, 9:15AM
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'New patent strengthens Adial's patent portfolio and covers AD04's unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorder'
Benzinga Newsdesk
-
Feb 28, 2024, 9:15AM
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Awarded New Patent From The United States PatentAnd Trademark Office
Benzinga Newsdesk
-
Feb 28, 2024, 9:15AM
Thursday, February 15, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 15, 2024, 4:31PM
Wednesday, February 14, 2024
Watching Adial Pharmaceuticals; Brookline Capital Markets Says 'We Believe The Announcement Of A New Patent Issuance Increases The Potential For Partners To Engage With The Company' Reiterates Buy And $26 Price Target"
Benzinga Newsdesk
-
Feb 14, 2024, 1:21PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch